Research News and Research

RSS

PharmAthene to provide update on contract modification suspension

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that in addition to its year end results, it will provide an update on the contract modification suspension it received on Friday, March 19, 2010.

22 Mar 2010

JDRF, Pfizer, Hadassah Medical Organization, The Hebrew University of Jerusalem form diabetes research collaboration

The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide, said today that it will begin a diabetes research collaboration with Pfizer, Hadassah Medical Organization, and The Hebrew University of Jerusalem on drugs to replicate and regenerate insulin-producing cells in people with type 1 diabetes.

22 Mar 2010

CRT, Cephalon to collaborate on development of small molecule inhibitors against cancer

Cancer Research Technology has announced an exclusive agreement with Cephalon, Inc., an international biotechnology company, to collaborate on the development of small molecule inhibitors. These molecules will target specific members of the 'protein kinase C' superfamily of cell signalling proteins - which have been shown to be associated with the development of cancer.

22 Mar 2010

EmSense releases new EmBand 24 neuromarketing measurement device

EmSense Corporation, the company that created the first scalable electroencephalography brainwave measurement technology, today announced the addition of the EmBand 24™ to the EmBand™ family of neuromarketing measurement devices.

22 Mar 2010

CRi to distribute 3DHISTECH’s digital slide scanners and software applications in North America

Cambridge Research & Instrumentation, Inc. (CRi), a leader in pre-clinical and molecular imaging, announced today that it has signed exclusive agreements to distribute 3DHISTECH’s full suite of digital slide scanners and software applications in North America, and the development and distribution of next generation product offerings that address growing applications in digital pathology. These agreements expand CRi’s offerings in the rapidly growing digital pathology market.

22 Mar 2010

Physiquality offers personalized health and fitness programs across the U.S.

Physiquality, a new national health and wellness network, now offers personalized health and fitness programs and products supervised by qualified physical and occupational therapists, across the United States.

22 Mar 2010

HHS announces 'Communities Putting Prevention to Work' grantee recipients: TFAH commends initiative

Trust for America's Health commends today's announcement by the U.S. Department of Health and Human Services of Communities Putting Prevention to Work grantee recipients. The landmark $327 million initiative will provide funding for a comprehensive, coordinated approach to community-based prevention activities that address physical activity, nutrition, obesity, and tobacco use.

22 Mar 2010

New global goals in the areas of nutrition, environment and workplace practices

PepsiCo, the world's second-largest food and beverage company, today announced new global goals in the areas of nutrition, the environment, and workplace practices at its investor conference here at the Legends Suite Club in Yankee Stadium.

22 Mar 2010

University of Maryland professor honored with the 2010 Stockholm Water Prize

Dr. Rita Colwell, distinguished Professor from the University of Maryland and John Hopkins University's Bloomberg School of Public Health in the United States, has been named the 2010 Stockholm Water Prize Laureate. Dr. Colwell's pioneering research on the prevention of waterborne infectious diseases has helped protect the health and lives of millions.

22 Mar 2010

Zenyaku Kogyo receives license to Theraclone Sciences' influenza monoclonal antibody program

Theraclone Sciences, Inc., announced that Zenyaku Kogyo Co. Ltd., has exercised its option for an exclusive license in the Japan territory to Theraclone’s influenza monoclonal antibody program. The collaboration utilizes Theraclone’s I-STAR™ technology to discover broadly protective monoclonal antibodies for the treatment of pandemic influenza and severe seasonal influenza.

22 Mar 2010

First Edition: March 22, 2010

Today's headlines detail yesterday's historic House vote on health reform while also looking forward to how action might play out in the Senate, how the legislative package impacts the current political dynamic and what its effects will be on consumers and stakeholders.

22 Mar 2010

Surgeon General to outline priorities at PCPCC Stakeholder's Summit

Surgeon General Regina Benjamin, MD, knows first-hand the connection doctors and patients need in order to address tough chronic health threats. Benjamin will discuss her priorities as Surgeon General in a keynote address at the Stakeholder's Summit of the Patient-Centered Primary Care Collaborative (PCPCC) at 10 a.m. on March 30 in Washington, DC.

22 Mar 2010

Psychologists study the effect of online ostracism on children

Research by psychologists at the University of Kent has revealed that online ostracism is a threat to children's self-esteem.

22 Mar 2010

Calando Pharmaceuticals demonstrates first targeted siRNA-containing nanoparticle delivery to tumors

Arrowhead Research Corporation today announced that the clinical trial being conducted by majority-owned subsidiary, Calando Pharmaceuticals, Inc., has demonstrated systemic delivery of siRNA and the successful “silencing” of a widely recognized cancer gene via RNA interference (RNAi) in humans.

22 Mar 2010

Simcere Pharmaceutical completes Phase IV clinical study of Endostar

Simcere Pharmaceutical Group, a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endostar (also known as Endu) in China, announced today the successful completion of Endostar Phase IV clinical study at a conference in Beijing dedicated to this study.

22 Mar 2010

Chao BRAIN Center receives $5M gift for study of progressive neurodegenerative diseases

Dr. Stephen Wong has received a $5 million gift from the Ting Tsung and Wei Fong Chao Foundation to study progressive neurodegenerative diseases including Alzheimer's Disease. The gift will support The Ting Tsung and Wei Fong Chao Center for Bioinformatics Research and Imaging for Neurosciences (BRAIN) at The Methodist Hospital Research Institute.

22 Mar 2010

The Purpose Institute to support Healthways' Vitality Quest initiative

Healthways, Inc., a Founding Member of The Purpose Institute, announced today that that the Institute has been engaged to support the Company’s recently announced Vitality QuestSM initiative to help communities committed to the health, well-being and productivity of their citizens become Healthways-Blue Zones Vitality CitiesSM

22 Mar 2010

iMDsoft's MetaVision suite of solutions to be distributed by Dominion in Spain

iMDsoft®, a global leader in hospital-wide clinical information systems, and Dominion, a leading provider of technology solutions in Spain and Latin America, have announced an agreement whereby Dominion will distribute iMDsoft's MetaVision® suite of solutions in Spain.

22 Mar 2010

Researchers develop new compound to inhibit HIV transmission

A compound that can inhibit the transfer of HIV from one cell to another has been developed by researchers at the Institut de Biologie Structurale Jean-Pierre Ebel.

22 Mar 2010

Removal of “no known cure” in house bill reduces SOMB’s power to prioritize public safety

House Bill 10-1364 is scheduled to be heard at the House Judiciary Committee at the Colorado capitol building the afternoon of Thursday, March 25. The bill deals in part with whether to keep the words "no known cure" in an existing statute governing Colorado's Sex Offender Management Board (SOMB). The SOMB oversees the state's treatment program for sex offenders.

22 Mar 2010

Research News and Research

PharmAthene to provide update on contract modification suspension

JDRF, Pfizer, Hadassah Medical Organization, The Hebrew University of Jerusalem form diabetes research collaboration

CRT, Cephalon to collaborate on development of small molecule inhibitors against cancer

EmSense releases new EmBand 24 neuromarketing measurement device

CRi to distribute 3DHISTECH’s digital slide scanners and software applications in North America

Physiquality offers personalized health and fitness programs across the U.S.

HHS announces 'Communities Putting Prevention to Work' grantee recipients: TFAH commends initiative

New global goals in the areas of nutrition, environment and workplace practices

University of Maryland professor honored with the 2010 Stockholm Water Prize

Zenyaku Kogyo receives license to Theraclone Sciences' influenza monoclonal antibody program

First Edition: March 22, 2010

Surgeon General to outline priorities at PCPCC Stakeholder's Summit

Psychologists study the effect of online ostracism on children

Calando Pharmaceuticals demonstrates first targeted siRNA-containing nanoparticle delivery to tumors

Simcere Pharmaceutical completes Phase IV clinical study of Endostar

Chao BRAIN Center receives $5M gift for study of progressive neurodegenerative diseases

The Purpose Institute to support Healthways' Vitality Quest initiative

iMDsoft's MetaVision suite of solutions to be distributed by Dominion in Spain

Researchers develop new compound to inhibit HIV transmission

Removal of “no known cure” in house bill reduces SOMB’s power to prioritize public safety

A guide to advancing biotherapeutic research eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence